Veterinary Molecular Diagnostics Market Size, Share, Growth, and Industry Analysis, By Types (Instruments, Reagents, Services, Software), By Applications Covered (Veterinary Hospitals, Clinical Laboratories, Research Institutes), Regional Insights and Forecast to 2035

Veterinary Molecular Diagnostics Market Size

The Global Veterinary Molecular Diagnostics Market size stood at USD 474.1 Million in 2025 and is anticipated to expand steadily, reaching USD 505.4 Million in 2026 and USD 538.75 Million in 2027, before growing to USD 898.35 Million by 2035. This positive growth outlook reflects a CAGR of 6.6% during the forecast period from 2026 to 2035, supported by rising pet adoption, increasing awareness of animal health, and technological advancements in PCR and sequencing diagnostics.

The US Veterinary Molecular Diagnostics Market showed strong growth in 2024 and is expected to continue its upward trajectory through 2025 and the forecast period. This growth is fueled by rising pet ownership, increasing awareness of animal health, and advancements in molecular diagnostic technologies for early and accurate detection of diseases in companion and livestock animals.

Key Findings

• Market Size: The Veterinary Molecular Diagnostics Market was valued at USD 444.7 million in 2024 and is projected to reach USD 790.4 million by 2033, reflecting a CAGR of 6.6% during the forecast period.
• Growth Drivers: Increasing pet ownership (35%), rising prevalence of zoonotic diseases (30%), advancements in molecular diagnostics (20%), and growing demand for accurate disease detection (15%) are key drivers.
• Trends: Integration of PCR technologies (25%), rise in point-of-care diagnostics (30%), expansion in personalized veterinary care (20%), and growing adoption in multiple animal species (25%) are notable trends.
• Key Players: IDEXX Laboratories, VCA, BAXIS, Heska, Zoetis, Neogen, Thermo Fisher Scientific, Virbac, GE Healthcare, AGFA Healthcare.
• Regional Insights: North America leads with 40% market share, driven by pet ownership and healthcare infrastructure, followed by Europe at 30% and Asia-Pacific at 25%.
• Challenges: High diagnostic test costs (30%), need for specialized training (25%), regulatory barriers (20%), and accuracy issues across animal populations (25%) limit market growth.
• Industry Impact: Veterinary molecular diagnostics enhance disease detection (40%), improve animal health management (30%), support public health (20%), and contribute to veterinary industry growth (10%).
• Recent Developments: In 2024, IDEXX Laboratories reported strong demand for veterinary diagnostics, with a 6% revenue increase from Companion Animal Group testing products.

The veterinary molecular diagnostics market is experiencing significant expansion due to the rising prevalence of zoonotic diseases, increasing pet ownership, and advancements in molecular diagnostic technologies. Veterinary clinics and research centers are widely adopting PCR and RT-PCR testing methods for detecting diseases such as avian influenza, bovine tuberculosis, and canine distemper. Companion animals account for over 60% of molecular testing applications due to the growing demand for early disease detection. Livestock diagnostics are also gaining momentum, especially in regions where food security and livestock productivity are critical, driving wider adoption of molecular tools in veterinary healthcare.

Veterinary Molecular Diagnostics Market Trends

The veterinary molecular diagnostics market is undergoing transformation with the integration of advanced technologies and growing emphasis on animal health surveillance. Polymerase Chain Reaction (PCR) remains the most widely used technique, accounting for nearly 55% of molecular diagnostics performed in veterinary settings. Real-Time PCR (RT-PCR) usage has increased by 28% over the last two years, particularly for high-throughput testing in livestock health monitoring. Over 40% of veterinary diagnostic laboratories have incorporated DNA sequencing for disease profiling and antimicrobial resistance tracking. Point-of-care testing kits using molecular technologies are witnessing a 35% rise in adoption, particularly in mobile veterinary units and small clinics. Companion animal diagnostics dominate with around 62% market share, driven by increased awareness of pet wellness and preventive healthcare. Bovine and swine applications together account for about 30% of testing volumes due to rising concerns around foodborne diseases and productivity. Europe and North America lead in technological penetration, each holding over 30% share in test volumes, while Asia-Pacific is expanding rapidly due to livestock disease outbreaks and increased government surveillance initiatives. Notably, private veterinary hospitals now contribute to 46% of total molecular diagnostic test consumption.

Veterinary Molecular Diagnostics Market Dynamics

With zoonotic diseases on the rise and the global focus shifting toward One Health initiatives, the market for veterinary molecular diagnostics is growing. Veterinary professionals are increasingly relying on nucleic acid-based diagnostic tools for rapid identification of infectious diseases, with over 50% of diagnostic decisions now influenced by molecular test results.

Drivers

"Rising adoption of PCR-based tests in companion animal diagnostics"

PCR-based diagnostics have grown by 42% in companion animal healthcare due to their high sensitivity and rapid turnaround. Approximately 64% of small animal clinics now use PCR panels to detect pathogens like parvovirus, giardia, and leptospira. The increased humanization of pets has led to a 38% rise in demand for preventive diagnostic screening. North America leads with over 45% of companion animal PCR diagnostics, while emerging markets in Asia are witnessing a 27% year-on-year rise in these tests.

Restraints

"Limited accessibility in rural and low-income regions"

Approximately 31% of rural veterinary clinics report lack of infrastructure to perform molecular testing. High costs associated with instruments and reagents have restricted market penetration, especially in developing nations. Over 22% of livestock owners depend on traditional diagnostics due to affordability constraints. In low-income economies, less than 15% of veterinary facilities are equipped with molecular diagnostic platforms, limiting their response to outbreaks.

Opportunity

"Growth in disease surveillance and livestock productivity programs"

Government-backed animal health programs have driven a 36% increase in molecular test volumes in livestock over the past two years. In Europe, over 40% of disease surveillance funding is directed toward PCR-based testing in cattle, swine, and poultry. Asia-Pacific countries such as China and India are investing in veterinary genomics and disease control, contributing to a 33% rise in molecular assay demand. Enhanced focus on food safety and traceability in the global meat supply chain is also creating demand for rapid, accurate molecular diagnostics.

Challenge

"Shortage of skilled personnel and standardization in molecular veterinary testing"

Nearly 29% of veterinary laboratories face a shortage of technicians trained in molecular diagnostics. Variability in test protocols and lack of standardized quality control measures result in a 24% discrepancy in diagnostic accuracy across clinics. Over 18% of labs report difficulty in maintaining reagent stability in high-temperature environments, affecting test sensitivity. Moreover, less than 35% of developing market laboratories follow GLP or ISO-compliant validation procedures, posing a barrier to accurate diagnostics and international collaborations.

Segmentation Analysis

The Veterinary Molecular Diagnostics Market is segmented based on type and application, each highlighting distinct areas of technological use and end-user demand in veterinary healthcare. By type, the market includes Instruments, Reagents, Services, and Software. Each component plays a critical role in the molecular diagnostics ecosystem. Instruments are essential hardware used in labs, while reagents are recurring consumables required for sample processing and testing. Services encompass diagnostic testing and technical support, while software supports data analysis and reporting. This combination of components ensures precise and efficient disease detection and monitoring in animals. By application, the market is segmented into Veterinary Hospitals, Clinical Laboratories, and Research Institutes. Veterinary hospitals lead in volume of diagnostics conducted, given their direct interaction with animal patients. Clinical laboratories, both standalone and affiliated with hospitals, perform large-scale testing and offer specialized diagnostics. Research institutes use molecular diagnostics to study emerging diseases, zoonotic risks, and veterinary therapeutics. These segments collectively support disease surveillance and animal health advancement globally.

By Type

• Instruments: Instruments account for nearly 30% of the veterinary molecular diagnostics market. These include PCR machines, nucleic acid extractors, and thermal cyclers, used to conduct genetic and infectious disease testing. Demand for advanced instruments is rising in veterinary clinics and research facilities to support high-throughput and automated workflows.
• Reagents: Reagents hold the largest share at around 40%. They are vital for each diagnostic test and are used in nucleic acid isolation, amplification, and detection processes. The recurring nature of reagent purchases makes this a high-volume segment, especially in laboratories conducting routine disease screening for livestock and companion animals.
• Services: Services contribute approximately 20% to the market. This includes diagnostic services provided by third-party labs, as well as instrument maintenance and technical support. Veterinary diagnostic service providers are expanding their capabilities to offer faster turnaround times and comprehensive pathogen panels, especially for poultry, swine, and equine health management.
• Software: Software represents about 10% of the market. These platforms assist in result interpretation, laboratory data management, and integration with veterinary healthcare records. As diagnostics become increasingly digitized, the need for efficient, AI-enabled software solutions to process and manage large volumes of molecular test data is rapidly increasing.

By Application

• Veterinary Hospitals: Veterinary hospitals account for approximately 45% of the total market share. These facilities are often the first point of care for pets and livestock and require rapid diagnostic tools to identify infectious and genetic conditions. The integration of molecular diagnostics supports timely decision-making and improves treatment accuracy in small and large animal care.
• Clinical Laboratories: Clinical laboratories hold around 35% of the market. These labs offer specialized testing services for veterinary clinics and hospitals. They handle high volumes of samples, often processing panels for viral, bacterial, and parasitic infections. Their expertise and infrastructure support wide-scale animal health monitoring across regions.
• Research Institutes: Research institutes contribute close to 20% of the market. These entities utilize molecular diagnostics for studying animal diseases, vaccine development, and understanding zoonotic transmission pathways. Many government-funded labs and academic institutions use advanced molecular tools to conduct surveillance for emerging pathogens and evaluate therapeutic outcomes in veterinary trials.

Regional Outlook

The Veterinary Molecular Diagnostics Market displays varied growth across regions due to differences in veterinary infrastructure, pet ownership trends, and livestock health management policies. North America leads the market due to advanced veterinary care systems, strong R&D infrastructure, and high companion animal spending. The region also benefits from widespread use of molecular diagnostics in zoonotic disease tracking and livestock disease control. Europe follows closely, with strong animal health regulation and public awareness driving diagnostic test usage. Countries like Germany, France, and the UK show significant integration of molecular technologies into routine veterinary diagnostics. Asia-Pacific is emerging as a high-growth region, driven by increasing investments in veterinary infrastructure and the rising prevalence of livestock diseases in countries like China, India, and Japan. Meanwhile, the Middle East & Africa region is gradually expanding, supported by growing animal husbandry practices and initiatives for animal health monitoring. Across all regions, demand for rapid, accurate diagnostics is driving adoption of molecular technologies in veterinary healthcare.

North America

North America accounts for approximately 40% of the global veterinary molecular diagnostics market. The United States holds the largest share within the region due to a high rate of pet adoption, large livestock populations, and advanced animal healthcare systems. Over 70% of veterinary hospitals and diagnostic labs in the U.S. employ molecular diagnostics for rapid pathogen detection and genetic analysis. Canada also plays a key role, particularly in livestock testing programs for bovine and swine diseases. The region’s regulatory focus on zoonotic disease prevention and antimicrobial resistance monitoring has further increased reliance on high-precision molecular tools. Robust investment in R&D and partnerships between veterinary service providers and diagnostic companies continue to support market expansion.

Europe

Europe holds around 30% of the veterinary molecular diagnostics market, with Germany, France, the UK, and Italy being major contributors. Germany leads the region, accounting for nearly 35% of Europe’s total demand, thanks to its well-established veterinary care system and focus on biosecurity in livestock farming. The UK and France show strong usage of molecular diagnostics in both companion and production animals. Over 60% of veterinary clinical labs across Western Europe utilize PCR-based testing for disease diagnosis and vaccine efficacy evaluation. Government support for animal health surveillance programs and disease eradication strategies has also boosted the demand for advanced molecular testing technologies in the region.

Asia-Pacific

Asia-Pacific accounts for approximately 22% of the global market and is the fastest-growing region. China dominates regional demand, with over 45% share, followed by Japan and India. China's large-scale livestock farming operations and concerns over zoonotic outbreaks have led to significant investment in veterinary diagnostics. In Japan, advanced diagnostic tools are used extensively for companion animal care and academic research. India’s rising demand is driven by growing awareness of animal health and the expansion of veterinary infrastructure. Across the region, more than 50% of veterinary labs are upgrading to molecular platforms to detect diseases like avian influenza, foot-and-mouth disease, and brucellosis, boosting the market significantly.

Middle East & Africa

The Middle East & Africa region contributes around 8% to the global veterinary molecular diagnostics market. The region is seeing increased adoption in countries like Saudi Arabia, the UAE, and South Africa. Saudi Arabia and the UAE together account for over 55% of regional demand, largely due to efforts to enhance livestock productivity and biosecurity. In Africa, South Africa leads with expanding diagnostic infrastructure in veterinary universities and public health laboratories. The focus on improving food safety, preventing cross-border disease transmission, and enhancing veterinary training is creating new opportunities for molecular diagnostics. However, limited access to advanced technologies in rural areas still presents a challenge, which governments and private players are working to address.

LIST OF KEY Veterinary Molecular Diagnostics Market COMPANIES PROFILED

• IDEXX Laboratories
• VCA
• BAXIS
• Heska
• Zoetis
• Neogen
• Thermo Fisher Scientific
• Virbac
• GE Healthcare
• AGFA Healthcare

Top companies having highest share

• IDEXX Laboratories: 18%
• Zoetis: 15%

Investment Analysis and Opportunities

The veterinary molecular diagnostics market is witnessing strong growth, fueled by increasing pet ownership, a rising focus on animal health, and advancements in diagnostic technology. Approximately 40% of the investments are focused on improving the speed and accuracy of diagnostics. With the rising demand for faster results, companies are working to shorten test durations, which is vital in diagnosing infectious diseases and genetic disorders in animals. The integration of real-time PCR and next-generation sequencing is playing a major role in improving diagnostic accuracy.

Around 35% of the investments are directed towards developing portable and user-friendly diagnostic devices. This trend is particularly significant in veterinary clinics, where small and easy-to-use devices are in demand. These innovations are especially crucial in developing economies, where veterinary infrastructure might not be as advanced, but the need for quality diagnostics is still high.

Another 15% of investments are being allocated to expanding diagnostic offerings in under-served regions, with particular emphasis on emerging markets such as Asia Pacific and Latin America. Additionally, 10% of the market investments are focused on enhancing disease detection for livestock, driven by growing concerns over zoonotic diseases and food security.

NEW PRODUCTS Development

In the veterinary molecular diagnostics market, new products are increasingly focusing on improving the convenience and accuracy of diagnostic testing. Approximately 45% of the new products being developed focus on point-of-care testing, which enables veterinarians to quickly diagnose animals in a clinic or field setting without the need for lab results. This has grown particularly important in veterinary practices that handle high volumes of pets and livestock, where quick diagnosis is essential to preventing outbreaks.

Another 35% of new products are centered around next-generation sequencing (NGS) platforms that offer enhanced sensitivity for genetic testing. These platforms are expected to greatly aid in identifying hereditary conditions and infectious diseases in animals, leading to earlier and more effective treatments.

Additionally, 15% of the focus is on enhancing the accuracy and range of disease-specific diagnostic tools, such as for chronic illnesses in pets like kidney disease and cancer. These products are designed to offer more detailed molecular insights into various diseases, helping veterinarians create personalized treatment plans.

Lastly, around 5% of product development efforts are being directed toward improving testing platforms that can be used for broader animal species, expanding their utility in wildlife conservation and exotic animal healthcare.

Recent Developments

• IDEXX Laboratories: In 2025, IDEXX Laboratories introduced a new PCR-based diagnostic kit that reduces the detection time for common canine diseases by 50%, leading to more efficient treatment plans.
• Thermo Fisher Scientific: In 2025, Thermo Fisher launched a veterinary-focused mobile diagnostic platform with integrated real-time data analysis, which enhances diagnostic precision and enables immediate results in rural veterinary clinics.
• Zoetis: In 2025, Zoetis unveiled a breakthrough in molecular diagnostic testing with a tool that identifies a wide range of viral and bacterial infections in pets, cutting down the time to diagnosis by 40%.
• Neogen: In 2025, Neogen released a portable device for detecting Salmonella and E. coli in livestock with a faster detection time, which is vital for reducing outbreaks in farming operations.
• Virbac: Virbac launched a new rapid diagnostic test in 2025 for feline leukemia virus (FeLV), enabling veterinarians to diagnose this disease in less than 10 minutes, significantly improving treatment outcomes.

REPORT COVERAGE

This report covers a comprehensive analysis of the veterinary molecular diagnostics market, highlighting key trends, market size, growth drivers, and the competitive landscape. It explores advancements in diagnostic technologies, such as PCR, next-generation sequencing, and point-of-care solutions, which are transforming the veterinary industry. The report delves into market dynamics, such as the increased focus on disease prevention and early detection in pets and livestock, driven by growing concerns over zoonotic diseases and animal health.

Furthermore, the report provides detailed insights into regional market performance, with a focus on North America, Europe, and the rapidly expanding Asia Pacific market, where the veterinary healthcare infrastructure is improving. It also examines strategic initiatives by key players, including product launches and mergers and acquisitions, which are influencing market growth. The report concludes by offering a future outlook, emphasizing opportunities in emerging markets and the increasing demand for advanced molecular diagnostics in veterinary care.